Dietary Supplements

Browse Dietary Supplements Content

CHPA’s President and CEO, Scott Melville, released a statement in response to the introduction of the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

May 27, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

May 25, 2022

CHPA’s President & CEO, Scott Melville, released a statement in response to the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

May 18, 2022

This report summarizes findings on issues associated with OTC drugs and dietary supplements in the environment with a focus on emerging issues and chemicals of concern.

May 2, 2022

CHPA President and CEO Scott Melville released a statement in response to Senator Durbin’s and Senator Braun’s Introduction of the Dietary Supplement Listing Act of 2022.

Apr 26, 2022

On this episode of CHPA Chat, we're talking about the booming business of dietary supplements, especially as a result of the COVID-19 pandemic. But class action lawsuits are also on the rise. In today's episode, we're discussing this real risk to companies and what they can do to get ready.

Apr 18, 2022

Filter Results